Antidepressant use and off-label prescribing in children and adolescent in Dutch general practice (2001-2005)

Pharmacoepidemiology and Drug Safety

Volumn 16, Issue 9, 2007, Pages 1054-1062

  Volkers, Anita C ^a   Heerdink, Eibert R ^b   van Dijk, Liset ^a  

^a NETHERLANDS INSTITUTE FOR HEALTH SERVICES RESEARCH   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Adolescents; Antidepressants; Children; General practice; Indications; Off label prescribing; Prescriptions

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CITALOPRAM; CLOMIPRAMINE; FLUOXETINE; FLUVOXAMINE; IMIPRAMINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ADOLESCENT; ANOREXIA NERVOSA; ANXIETY DISORDER; ARTICLE; BULIMIA; CHILD; CHILD HEALTH CARE; DEPRESSION; DRUG INDICATION; DRUG SAFETY; DRUG UTILIZATION; FEMALE; GENERAL PRACTICE; GENERAL PRACTITIONER; HUMAN; HYPERACTIVITY; INFANT; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; NEUROPATHIC PAIN; NEWBORN; NOCTURNAL ENURESIS; OFF LABEL DRUG USE; PERSONALITY DISORDER; PRESCRIPTION; PRIORITY JOURNAL; SLEEP DISORDER; TOBACCO DEPENDENCE;

ADOLESCENT; ADRENERGIC UPTAKE INHIBITORS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; ANTIDEPRESSIVE AGENTS, TRICYCLIC; ANXIETY DISORDERS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; CYCLOHEXANOLS; DEPRESSIVE DISORDER; DRUG LABELING; DRUG UTILIZATION; FAMILY PRACTICE; FEMALE; HUMANS; IMIPRAMINE; MALE; NETHERLANDS; NOCTURNAL ENURESIS; PAROXETINE; PHYSICIAN'S PRACTICE PATTERNS; PRESCRIPTIONS, DRUG; SEROTONIN UPTAKE INHIBITORS; TENSION-TYPE HEADACHE; TIME FACTORS;

EID: 34548743533     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.1430     Document Type: Article

References (31)

1. Zito JM, Safer DJ, DosReis S, et al. Psychotropic practice patterns for youth: a 10-year perspective. Arch Pediatr Adolesc Med 2003; 157(1): 17-25.
2. Delate T, Gelenberg AJ, Simmons VA, Motherhal BR. Trends in the use of antidepressants in a national sample of commercially insured pediatric patients, 1998 to 2002. Psychiatr Serv 2004; 55(4): 387-391.
3. Hugtenburg JG, Heerdink ER, Egberts AC. Increased psychotropic drug consumption by children in the Netherlands during 1995-2001 is caused by increased use of methylphenidate by boys. Eur J Clin Pharmacol 2004; 60(5): 377-379. Epub 2004 May 28.
4. Wong IC, Murray ML, Cailleri-Novak D, Stephens P. Increased prescribing trends of paediatric psychotropic medications. Arch Dis Child 2004; 89(12): 1131-1132.
5. Jureidini JN, Doecke CJ, Mansfield PR, Haby MM, Menkes DB, Tonkin AI. Efficacy and safety of antidepressants for children and adolescents. Br Med J 2004; 328(7444): 879-883.
6. Medicines and Healthcare products Regulatory Agency (MHRA). Seroxat must not be used for treatment in children. June 2003. http://www.mhra.gov.uk/ home (accessed 28 March 2007).
7. Dutch Medicines Evaluation Board. Dutch Medicines Evaluation Board advices to be careful when using SSRIs in children with a depressive disorder.[in Dutch] December 2003. URL: htt://www.homer.nl/cbg-meb/ index.html?taal=nl (accessed 28 March 2007).
8. Medicines and Healthcare products Regulatory Agency (MHRA). Safety review of antidepressants used by children completed. URL: http://www.mhra.gov.uk/home (accessed 28 March 2007).
9. US Food and Drug Administration (FDA). Worsening depression and suicidality in patients being treated with anti-depressant. URL: http://www.fda.gov/cder/drug/antidepressants/AntidepressanstPHA.htm (accessed 28 March 2007).
10. European Medicine agency (EMEA). CHMP meeting on Paroxetine and other SSRIs. December 2004. URL: http://www.cbg-meb.nl/nl/docs/nieuws/ pb-paroxetine.pdf (accessed 28 March 2007).
11. Dutch Medicines Evaluation Board. Antidepressants in children. [in Dutch] December 2004. URL: http://www.cbg-meb.nl/nl/nieuws/index.htm (accessed 28 March 2007).
12. Bennett K, Teeling M, Feely J. Overprescribing antidepressants to children: pharmacoepidemiological study in primary care. Br Med J 2005; 331(7530): 1451-1452.
13. Kurian BT, Arbogast PG, Ray WA, Fuchs DC, Cooper WO. Effect of government regulatory changes on SSRI prescriptions in children. Pharmacoepidemiol Drug Saf 2006; 15 (Suppl.): S33.
14. Volkers A, de Jong A, de Bakker D, van Dijk L. Effective prescribing antidepressants in general practice. (in Dutch). NIVEL: Utrecht, the Netherlands, 2005.
15. Dutch Medicines Evaluation Board (MEB). URL: http://www.cbg-meb.n/ (accessed 28 March 2007).
16. Efron D, Hiscock H, Sewell JR, et al. Prescribing of psychotropic medications for children by Australian pediatricians and child psychiatrists. Pediatrics 2003; 111(2): 372-375.
17. Hugtenburg JG. Heerdink ER, Tso YH. Psychoactive drug prescribing by Dutch child and adolescent psychiatrists. Acta Paediatr 2005; 94(10): 1484-1487.
18. Verheij RA, te Brake H, Abrahamse HA, Hoogen van den H, Braspenning J, van Althuis T. Netherlands Information Network of General Practice. Facts and figures about general practitioner care in the Netherlands. NIVEL/WOK: Utrecht/Nijmegen, the Netherlands. URL: http://www.LINH.nl (accessed 28 March 2007).
19. Verheij R, van der Zee J. Collecting information in general practice: 'just by pressing a single button'? In Morbidity, performance and quality in primary care. Dutch general practice on stage, Westert GP, Jabaaij L, Schellevis FG (eds). Radcliffe Publishing Ltd.: Oxon, UK, 2006: 265-272.
20. WONCA Classification Committee. ICHPPC-2-Defined inclusion criteria for the use of the rubrics of the International Classification of Health Problems in Primary care. Oxford University Press: Oxford, UK, 2003.
21. Dutch Medicines Evaluation Board (MEB). http://www.cbg-meb.nl/uk/ prodinfo/index.htm (accessed 28 March).
22. Pharmaceutical Compass of the Dutch Health Care Insurance Board. www.fk.cvz.nl (assessed 28 March 2007).
23. Dutch College of general practitioners (NHG). www.formularium.nl/nhgevs (assessed 28 March 2007).
24. Schirm E, Tobi H, Zito JM, de Jong-van den Berg LT. Psychotropic medication in children: a study from the Netherlands. Pediatrics 2001; 108(2): E25.
25. Mancini J, Thirion X, Masut A, et al. Anxiolytics, hypnotics, and antidepressants dispensed to adolescents in a French region in 2002. Pharmacoepidemiol Drug Saf 2006; 15(7): 494-503.
26. Levy L, Martin-Guehl C, Lechevallier-Michel N, et al. Use of psychotropic drugs in 0 to 5 years old children in Aquitaine (France): prevalence and associated factors. Pharmacoepidemiol Drug Saf 2006; 15(7): 504-509.
27. Gardarsdottir H, Heerdink ER, van Dijk L, Egberts ACG. Indications for antidepressant drug prescribing in general practice in the Netherlands. J Affect Disord 2007; 98: 109-115.
28. McIntyre J, Conroy S, Avery A, Corns H, Choonara I. Unlicensed and off label prescribing of drugs in general practice. Arch Dis Child 2000; 83(6): 498-501.
29. Ekins-Daukes S, Helms PJ, Simpson CR, Taylor MW, McLay JS. Off-label prescribing to children in primary care: retrospective observational study. Eur J Clin Pharmacol 2004; 60(5): 349-353.
30. Schirm E, Tobi H, de Jong-van den Berg LT. Unlicensed and off label drug use by children in the community: cross sectional study. Br Med J 2002; 324(7349): 1312-1313.
31. Cohen D. Should the use of selective serotonin reuptake inhibitors in child and adolescent depression be banned? Psychother Psychosom 2007; 76(1): 5-14.